AMRZ insider award: 2,958 restricted shares granted to director

Rhea-AI Filing Summary

Wilbur Maria Cristina Alapag, a director of Amrize Ltd (AMRZ), reported an equity award on 08/11/2025: a grant of 2,958 restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was issued with a $0 purchase price and will vest on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

After the reported transaction the reporting person held 3,148 ordinary shares beneficially. The filing is a routine director equity award that documents the grant size, vesting condition, and post-transaction ownership level.

Insights

Securities Analyst

TL;DR Director received a 2,958-unit RSU grant under the 2025 Omnibus Plan; post-grant ownership is 3,148 shares.

This Form 4 discloses a non-cash, restricted stock unit award to a director with customary vesting tied to time and the next annual meeting. The $0 price indicates an award rather than a market purchase. For investors, this is a routine compensation disclosure that updates insider ownership figures but does not, by itself, change the company’s capital structure or cash position.

Corporate Governance Expert

TL;DR A standard director compensation grant with time-based vesting; disclosure aligns with Section 16 reporting requirements.

The filing documents an equity-based retention/incentive instrument under the stated Omnibus Incentive Plan. The explicit vesting condition—earlier of one-year anniversary or next annual meeting—is clear and limited in duration. This is a governance-typical disclosure that improves transparency about director incentives and current beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilbur Maria Cristina Alapag

(Last) (First) (Middle)

GRAFENAUWEG 8

(Street)

ZUG V8 6300

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2025		A		2,958(1)	A	$0	3,148	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

	Hans Weinburger, Attorney-in-Fact	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Wilbur Maria Cristina Alapag report on Form 4 for AMRZ?

The report discloses a grant of 2,958 restricted stock units (RSUs) to the reporting person under the Amrize Ltd 2025 Omnibus Incentive Plan.

When was the RSU award for AMRZ reported and what is the vesting condition?

The transaction date shown is 08/11/2025, and the award vests on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

Did the director pay cash for the shares reported on the Form 4 (AMRZ)?

No cash consideration was reported; the price is shown as $0, indicating a grant rather than a purchase.

How many AMRZ shares does the reporting person own after the transaction?

The filing reports 3,148 ordinary shares beneficially owned following the reported transaction.

What role does the reporting person hold at Amrize Ltd (AMRZ)?

The Form 4 indicates the reporting person, Wilbur Maria Cristina Alapag, is a Director of Amrize Ltd.